AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 282: H232-H236, 2002;
0363-6135/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shastry, S.
Right arrow Articles by Joyner, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shastry, S.
Right arrow Articles by Joyner, M. J.
Vol. 282, Issue 1, H232-H236, January 2002

Geldanamycin attenuates NO-mediated dilation in human skin

Shubha Shastry2 and Michael J. Joyner1

1 Departments of Anesthesiology and Physiology and 2 Biophysics, Mayo Clinic and Foundation, Rochester, Minnesota 55905

The binding of heat shock protein 90 (HSP90) to endothelial nitric oxide (NO) synthase (eNOS) can enhance eNOS activation. Studies have shown that the HSP90-specific inhibitor geldanamycin (GA) can cause attenuation of NO-mediated processes. Twenty subjects participated in one of two protocols. In each protocol, one forearm of each subject was instrumented with two intradermal microdialysis probes for drug delivery. Laser Doppler flowmeters were used to measure cutaneous blood flow. Skin sites were either treated with the endothelial agonist acetylcholine or locally heated to 42°C, a maneuver that evokes NO-mediated dilation. Interventions were performed with and without GA. In the presence of GA, maximal cutaneous vascular conductance (CVC) to ACh was 20 ± 3% lower than with ACh alone (P < 0.001). During local heating, maximal CVC in the presence of GA was 22 ± 6% lower than during heating alone (P < 0.01). The results show that GA can attenuate NO-mediated dilation in human skin, suggesting a potential role for HSP90 in activation of eNOS in the microcirculation.

heat shock protein 90; microdialysis; endothelial nitric oxide synthases; endothelium


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. L. Kellogg Jr., J. L. Zhao, and Y. Wu
Endothelial nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H123 - H129.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
D. L. Kellogg Jr, J. L. Zhao, and Y. Wu
Neuronal nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo
J. Physiol., February 1, 2008; 586(3): 847 - 857.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
K. Kimura, D. A. Low, D. M. Keller, S. L. Davis, and C. G. Crandall
Cutaneous blood flow and sweat rate responses to exogenous administration of acetylcholine and methacholine
J Appl Physiol, May 1, 2007; 102(5): 1856 - 1861.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. Yetik-Anacak, T. Xia, C. Dimitropoulou, R. C. Venema, and J. D. Catravas
Effects of hsp90 binding inhibitors on sGC-mediated vascular relaxation
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H260 - H268.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
D. L. Kellogg Jr
In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges
J Appl Physiol, May 1, 2006; 100(5): 1709 - 1718.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. Ou, J. T. Fontana, Z. Ou, D. W. Jones, A. W. Ackerman, K. T. Oldham, J. Yu, W. C. Sessa, and K. A. Pritchard Jr.
Heat shock protein 90 and tyrosine kinase regulate eNOS NO{middle dot} generation but not NO{middle dot} bioactivity
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H561 - H569.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online